| Structural insight into allosteric modulation of protease-activated receptor 2 RKY Cheng, C Fiez-Vandal, O Schlenker, K Edman, B Aggeler, DG Brown, ... Nature 545 (7652), 112-115, 2017 | 240 | 2017 |
| Discovery of Clinical Candidate 1-{[(2S,3S,4S)-3-Ethyl-4-fluoro-5-oxopyrrolidin-2-yl]methoxy}-7-methoxyisoquinoline-6-carboxamide (PF-06650833), a Potent … KL Lee, CM Ambler, DR Anderson, BP Boscoe, AG Bree, JI Brodfuehrer, ... Journal of medicinal chemistry 60 (13), 5521-5542, 2017 | 128 | 2017 |
| Imidazo [1, 5-a] quinoxalines as irreversible BTK inhibitors for the treatment of rheumatoid arthritis KH Kim, A Maderna, ME Schnute, M Hegen, S Mohan, J Miyashiro, L Lin, ... Bioorganic & medicinal chemistry letters 21 (21), 6258-6263, 2011 | 103 | 2011 |
| Fragment‐based screen against HIV protease AL Perryman, Q Zhang, HH Soutter, R Rosenfeld, DE McRee, AJ Olson, ... Chemical biology & drug design 75 (3), 257-268, 2010 | 88 | 2010 |
| Discovery of a potent BTK inhibitor with a novel binding mode by using parallel selections with a DNA‐encoded chemical library JW Cuozzo, PA Centrella, D Gikunju, S Habeshian, CD Hupp, AD Keefe, ... ChemBioChem 18 (9), 864-871, 2017 | 78 | 2017 |
| Isoform-selective ATAD2 chemical probe with novel chemical structure and unusual mode of action AE Fernández-Montalván, M Berger, B Kuropka, SJ Koo, V Badock, ... ACS chemical biology 12 (11), 2730-2736, 2017 | 77 | 2017 |
| Structure based design of non-natural peptidic macrocyclic Mcl-1 inhibitors JW Johannes, S Bates, C Beigie, MA Belmonte, J Breen, S Cao, ... ACS medicinal chemistry letters 8 (2), 239-244, 2017 | 72 | 2017 |
| Structure Guided Development of Novel Thymidine Mimetics Targeting Pseudomonas aeruginosa Thymidylate Kinase: From Hit to Lead Generation JY Choi, MS Plummer, J Starr, CR Desbonnet, H Soutter, J Chang, ... Journal of medicinal chemistry 55 (2), 852-870, 2012 | 61 | 2012 |
| Discovery of cofactor-specific, bactericidal Mycobacterium tuberculosis InhA inhibitors using DNA-encoded library technology HH Soutter, P Centrella, MA Clark, JW Cuozzo, CE Dumelin, MA Guie, ... Proceedings of the National Academy of Sciences 113 (49), E7880-E7889, 2016 | 51 | 2016 |
| Anti-IL-12/IL-23 antibodies and uses thereof DW Borhani, R Sadhukhan, SE Lacy, HH Soutter US Patent App. 13/374,693, 2012 | 49 | 2012 |
| Agonists and antagonists of protease-activated receptor 2 discovered within a DNA-encoded chemical library using mutational stabilization of the target DG Brown, GA Brown, P Centrella, K Certel, RM Cooke, JW Cuozzo, ... SLAS DISCOVERY: Advancing the Science of Drug Discovery 23 (5), 429-436, 2018 | 43 | 2018 |
| Discovery of a structural class of antibiotics with explainable deep learning F Wong, EJ Zheng, JA Valeri, NM Donghia, MN Anahtar, S Omori, A Li, ... Nature 626 (7997), 177-185, 2024 | 22 | 2024 |
| Overview of recent progress in protein-expression technologies for small-molecule screening JW Cuozzo, HH Soutter Journal of Biomolecular Screening 19 (7), 1000-1013, 2014 | 11 | 2014 |
| Design of a systemic small molecule clinical STING agonist using physics-based simulations and artificial intelligence BK Allen, MM Kulkarni, B Chamberlain, T Dwight, C Koh, R Samant, ... Biorxiv, 2022.05. 23.493001, 2022 | 10 | 2022 |
| Discovery of clinical candidate PF-06650833: a potent, selective, and efficient inhibitor of IRAK4 from fragment-based drug design K Lee, C Allais, C Ambler, D Anderson, B Boscoe, A Bree, J Brodfuehrer, ... ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 251, 2016 | 2 | 2016 |
| DNA-encoded macrocyclic compound libraries for challenging targets Y Zhang, A Keefe, P Centrella, J Cuozzo, H Soutter, D Resnicow, ... Cancer Research 83 (7_Supplement), 5331-5331, 2023 | | 2023 |
| Structure Guided Development of Novel Thymidine Mimetics Targeting Pseudomonas aeruginosa Thymidylat JY Choi, MS Plummer, J Starr, CR Desbonnet, H Soutter, J Chang, ... J. Med. Chem. 55 (2)), 2021 | | 2021 |
| Abstract LB-A20: True small molecule STING agonist generates systemic and potent anti-tumor immunity required for effective cancer immunotherapy MM Kulkarni, T Dwight, K Marino, BK Allen, M Taimi, C Bastos, S Lai, ... Molecular Cancer Therapeutics 18 (12_Supplement), LB-A20-LB-A20, 2019 | | 2019 |
| True small molecule STING agonist generates systemic and potent anti-tumor immunity required for effective cancer immunotherapy MM Kulkarni, T Dwight, K Marino, BK Allen, M Taimi, C Bastos, S Lai, ... MOLECULAR CANCER THERAPEUTICS 18 (12), 2019 | | 2019 |
| Tackling challenging targets in innate immune pathways with integrated biophysics and simulation H Soutter, I Kolossvary, K Marino, S Sparks, H Xu, W Sherman ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 258, 2019 | | 2019 |
